Subasri Narasimhan, PhD, Emory University

Subasri (Suba) Narasimhan completed her PhD in Community Health Sciences at the University of California Los Angeles Fielding School of Public Health where she was a Bixby Doctoral Fellow, Child and Family Health Trainee, and a Eunice Kennedy Shriver National Institutes of Child Health and Development Pre-Doctoral Trainee. Her MPH in Maternal and Child Health ...Read more >

Christopher Ahlbach, BS, University of California, San Francisco

Despite its critical importance in reproductive health, access to safe abortion care in the US and globally continues to be impaired by laws and policies based on religious, political, or other ideologies. Although there is substantial anecdotal evidence about specific beliefs and rationales for opposing abortion provision, identifying specific attitudes, and exploring how those attitudes ...Read more >

Kelly Ward, MA, University of California, Irvine

Medical assistants (MAs) have been largely overlooked in research on abortion providers. The proposed research narrows that gap by documenting the integral role MAs play in abortion care. MAs are a rapidly growing occupational group in healthcare and often come to abortion work without a prior ideological commitment to reproductive rights. Using ethnographic methods, I ...Read more >

Elizabeth Bartelt, MPH, Indiana University

This study will examine the experiences of sexual and gender minority (SGM) young people who have had at least one abortion. This study will be innovative by lifting voices of those who are typically excluded from traditional women’s health research and practice. The overall focus of this study will be on understanding SGM young people’s ...Read more >

April Bell, MPH, Indiana University

April J. Bell has designed and implemented data collection and evaluation systems in domestic and international settings. She received her BA in Human Biology from Stanford University, her MPH with a dual concentration in Epidemiology and Social and Behavioral Sciences from the School of Medicine at Indiana University (IU) and is a PhD candidate in ...Read more >

Chinelo Okigbo, MD, PhD, MPH, University of North Carolina at Chapel Hill

Objective: Pre-gestational diabetes increases the risks of adverse maternal and neonatal pregnancy outcomes such as preeclampsia, preterm delivery, neonatal macrosomia, and birth defects. These risks are further increased if the pregnancy was unplanned. This study aims to examine the prevalence, predictors, and consequences of unplanned pregnancy among women of reproductive age with pre-gestational diabetes in ...Read more >

Kathleen Broussard, MA, University of Texas at Austin

Developments in new medical technologies and increased access to health-related information online have led to a surge in self-care or “DIY medicine,” loosely defined as the attempt by lay people to self-manage their healthcare outside of the formal medical setting. This study will explore the influence of social networks on a particularly stigmatized health behavior: ...Read more >

Katharine White, MD MPH, Boston Medical Center

Access to abortion is becoming increasingly difficult in the era of state-mandated Targeted Regulation of Abortion (TRAP) laws. Of particular concern is the so-called “heartbeat” law, wherein abortion is deemed illegal after visualization of fetal cardiac activity. These laws may prohibit abortion access as early as after six weeks gestation, effectively eliminating access to the ...Read more >

Sarah Prager, MD, MAS, University of Washington

Abortion restrictions and subsequent publicity on self-induced abortion have increased in the United States, raising safety concerns about these clandestine and stigmatized abortion practices. Meanwhile, anecdotal evidence from underground abortion providers outside the formal healthcare system suggests that they are administering safe and effective abortions. No in-depth studies have been published on the scope, services, ...Read more >

Whitney Rice, DrPH, University of Alabama at Birmingham

Approximately 100,000 abortions occur annually in Canada, of which 96% have been provided using surgery to date. Mifepristone, the gold standard for medical abortion, was made available for the first time in Canada in January 2017. The availability of mifepristone has particular potential to improve care for women in rural and remote communities, who currently ...Read more >

1 2 3 7